Title of article
Diabetes and the COVID-19 Pandemic: What Should the Diabetes Patients Know?
Author/Authors
Shahwan, Moyad College of Pharmacy and Health Sciences - Ajman University, Ajman, United Arab Emirates , Hassan, Nageeb College of Pharmacy and Health Sciences - Ajman University, Ajman, United Arab Emirates , Alkhoujah, Sahab College of Pharmacy and Health Sciences - Ajman University, Ajman, United Arab Emirates , Jairoun, Ammar Health and Safety Department - Dubai Municipality, UAE , Zyoud, Samer College of Humanities and Sciences - Ajman University, Ajman, United Arab Emirates , Varma, Sudhir College of Dentistry - Ajman University, Ajman, United Arab Emirates
Pages
4
From page
87
To page
90
Abstract
Cases of respiratory disease have been caused by the outbreak of the novel coronavirus named COVID-19: “CO” for corona, “VI” for virus, and “D” for disease. The “19” represents 2019, the year the infection started in Wuhan City, China, since when it has since spread worldwide. COVID-19 ranges in severity from a mild, flu-like disease through pneumonia and respiratory failure to death. Severe
symptoms, complications, and a high risk of infection are associated with elderly patients, along with chronic diseases like diabetes, as reported in a recent study.
Keywords
COVID-19 , Diabetic , Policy makers
Journal title
Pharmaceutical Sciences
Serial Year
2020
Record number
2522283
Link To Document